nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—CYP2C9—Disulfiram—alcohol dependence	0.233	1	CbGbCtD
Valsartan—Hypogeusia—Citalopram—alcohol dependence	0.0216	0.0389	CcSEcCtD
Valsartan—Dizziness postural—Citalopram—alcohol dependence	0.0107	0.0193	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—PECR—alcohol dependence	0.0102	0.0588	CbGpPWpGaD
Valsartan—SLCO1B3—Transport of organic anions—AVP—alcohol dependence	0.00839	0.0483	CbGpPWpGaD
Valsartan—Loss of libido—Citalopram—alcohol dependence	0.00812	0.0146	CcSEcCtD
Valsartan—Erectile dysfunction—Disulfiram—alcohol dependence	0.00733	0.0132	CcSEcCtD
Valsartan—AGTR1—Peptide GPCRs—OPRK1—alcohol dependence	0.00665	0.0383	CbGpPWpGaD
Valsartan—Hepatitis—Disulfiram—alcohol dependence	0.00637	0.0115	CcSEcCtD
Valsartan—Hepatic enzyme increased—Naltrexone—alcohol dependence	0.00625	0.0112	CcSEcCtD
Valsartan—Blood pressure increased—Naltrexone—alcohol dependence	0.00592	0.0106	CcSEcCtD
Valsartan—SLCO1B1—Transport of organic anions—AVP—alcohol dependence	0.00564	0.0324	CbGpPWpGaD
Valsartan—Renal failure acute—Acamprosate—alcohol dependence	0.00492	0.00884	CcSEcCtD
Valsartan—Swelling—Naltrexone—alcohol dependence	0.00487	0.00875	CcSEcCtD
Valsartan—Dermatitis bullous—Acamprosate—alcohol dependence	0.00475	0.00854	CcSEcCtD
Valsartan—Cardiac failure—Acamprosate—alcohol dependence	0.00465	0.00836	CcSEcCtD
Valsartan—Ageusia—Citalopram—alcohol dependence	0.00463	0.00832	CcSEcCtD
Valsartan—Hyponatraemia—Acamprosate—alcohol dependence	0.00456	0.0082	CcSEcCtD
Valsartan—Atrial fibrillation—Naltrexone—alcohol dependence	0.00453	0.00815	CcSEcCtD
Valsartan—AGTR1—Peptide GPCRs—OPRD1—alcohol dependence	0.00447	0.0257	CbGpPWpGaD
Valsartan—Blood creatinine increased—Acamprosate—alcohol dependence	0.00425	0.00765	CcSEcCtD
Valsartan—Rhabdomyolysis—Citalopram—alcohol dependence	0.00424	0.00762	CcSEcCtD
Valsartan—Viral infection—Citalopram—alcohol dependence	0.00415	0.00746	CcSEcCtD
Valsartan—Orthostatic hypotension—Acamprosate—alcohol dependence	0.00414	0.00746	CcSEcCtD
Valsartan—Paraesthesia—Disulfiram—alcohol dependence	0.00407	0.00731	CcSEcCtD
Valsartan—Drug interaction—Citalopram—alcohol dependence	0.00404	0.00727	CcSEcCtD
Valsartan—Somnolence—Disulfiram—alcohol dependence	0.00403	0.00724	CcSEcCtD
Valsartan—Hepatic enzyme increased—Citalopram—alcohol dependence	0.00396	0.00713	CcSEcCtD
Valsartan—Abdominal pain upper—Naltrexone—alcohol dependence	0.00392	0.00705	CcSEcCtD
Valsartan—Fatigue—Disulfiram—alcohol dependence	0.0039	0.00702	CcSEcCtD
Valsartan—Cramp muscle—Naltrexone—alcohol dependence	0.00387	0.00695	CcSEcCtD
Valsartan—Bronchitis—Acamprosate—alcohol dependence	0.00377	0.00679	CcSEcCtD
Valsartan—Blood pressure increased—Citalopram—alcohol dependence	0.00375	0.00674	CcSEcCtD
Valsartan—Erectile dysfunction—Acamprosate—alcohol dependence	0.00361	0.0065	CcSEcCtD
Valsartan—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00358	0.00644	CcSEcCtD
Valsartan—Bronchitis—Naltrexone—alcohol dependence	0.00357	0.00642	CcSEcCtD
Valsartan—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00345	0.0062	CcSEcCtD
Valsartan—AGTR1—Peptide GPCRs—OPRM1—alcohol dependence	0.00344	0.0198	CbGpPWpGaD
Valsartan—Infestation—Naltrexone—alcohol dependence	0.00331	0.00595	CcSEcCtD
Valsartan—Infestation NOS—Naltrexone—alcohol dependence	0.00331	0.00595	CcSEcCtD
Valsartan—Epistaxis—Acamprosate—alcohol dependence	0.0033	0.00593	CcSEcCtD
Valsartan—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00327	0.0188	CbGpPWpGaD
Valsartan—Asthenia—Disulfiram—alcohol dependence	0.00325	0.00584	CcSEcCtD
Valsartan—ALB—Transport of organic anions—AVP—alcohol dependence	0.00322	0.0185	CbGpPWpGaD
Valsartan—Haemoglobin—Acamprosate—alcohol dependence	0.00316	0.00568	CcSEcCtD
Valsartan—Rhinitis—Acamprosate—alcohol dependence	0.00315	0.00566	CcSEcCtD
Valsartan—Haemorrhage—Acamprosate—alcohol dependence	0.00314	0.00565	CcSEcCtD
Valsartan—Hepatitis—Acamprosate—alcohol dependence	0.00314	0.00565	CcSEcCtD
Valsartan—AGTR1—Peptide ligand-binding receptors—OPRK1—alcohol dependence	0.00313	0.018	CbGpPWpGaD
Valsartan—Epistaxis—Naltrexone—alcohol dependence	0.00312	0.00561	CcSEcCtD
Valsartan—Pharyngitis—Acamprosate—alcohol dependence	0.00312	0.0056	CcSEcCtD
Valsartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—AVP—alcohol dependence	0.00311	0.0179	CbGpPWpGaD
Valsartan—Sinusitis—Naltrexone—alcohol dependence	0.0031	0.00558	CcSEcCtD
Valsartan—Dizziness—Disulfiram—alcohol dependence	0.00299	0.00539	CcSEcCtD
Valsartan—Hepatitis—Naltrexone—alcohol dependence	0.00297	0.00534	CcSEcCtD
Valsartan—Pharyngitis—Naltrexone—alcohol dependence	0.00295	0.0053	CcSEcCtD
Valsartan—Renal failure acute—Citalopram—alcohol dependence	0.00295	0.0053	CcSEcCtD
Valsartan—Connective tissue disorder—Naltrexone—alcohol dependence	0.00292	0.00525	CcSEcCtD
Valsartan—Atrial fibrillation—Citalopram—alcohol dependence	0.00287	0.00516	CcSEcCtD
Valsartan—Rash—Disulfiram—alcohol dependence	0.00285	0.00514	CcSEcCtD
Valsartan—Dermatitis bullous—Citalopram—alcohol dependence	0.00285	0.00512	CcSEcCtD
Valsartan—Headache—Disulfiram—alcohol dependence	0.00284	0.0051	CcSEcCtD
Valsartan—Immune system disorder—Acamprosate—alcohol dependence	0.00284	0.0051	CcSEcCtD
Valsartan—Cardiac failure—Citalopram—alcohol dependence	0.00279	0.00501	CcSEcCtD
Valsartan—Alopecia—Acamprosate—alcohol dependence	0.00277	0.00499	CcSEcCtD
Valsartan—Cardiac disorder—Naltrexone—alcohol dependence	0.00276	0.00496	CcSEcCtD
Valsartan—Mental disorder—Acamprosate—alcohol dependence	0.00275	0.00495	CcSEcCtD
Valsartan—AGTR1—forebrain—alcohol dependence	0.00273	0.0741	CbGeAlD
Valsartan—Malnutrition—Acamprosate—alcohol dependence	0.00273	0.00492	CcSEcCtD
Valsartan—Hyponatraemia—Citalopram—alcohol dependence	0.00273	0.00491	CcSEcCtD
Valsartan—Angiopathy—Naltrexone—alcohol dependence	0.00269	0.00485	CcSEcCtD
Valsartan—Flatulence—Acamprosate—alcohol dependence	0.00269	0.00484	CcSEcCtD
Valsartan—Immune system disorder—Naltrexone—alcohol dependence	0.00268	0.00483	CcSEcCtD
Valsartan—Mediastinal disorder—Naltrexone—alcohol dependence	0.00268	0.00482	CcSEcCtD
Valsartan—Dysgeusia—Acamprosate—alcohol dependence	0.00268	0.00481	CcSEcCtD
Valsartan—Back pain—Acamprosate—alcohol dependence	0.00264	0.00476	CcSEcCtD
Valsartan—Muscle spasms—Acamprosate—alcohol dependence	0.00263	0.00473	CcSEcCtD
Valsartan—Alopecia—Naltrexone—alcohol dependence	0.00262	0.00472	CcSEcCtD
Valsartan—SLCO1B3—endocrine gland—alcohol dependence	0.00261	0.0708	CbGeAlD
Valsartan—Mental disorder—Naltrexone—alcohol dependence	0.0026	0.00468	CcSEcCtD
Valsartan—Malnutrition—Naltrexone—alcohol dependence	0.00259	0.00465	CcSEcCtD
Valsartan—Flatulence—Naltrexone—alcohol dependence	0.00255	0.00458	CcSEcCtD
Valsartan—AGTR1—adrenal cortex—alcohol dependence	0.00253	0.0686	CbGeAlD
Valsartan—Dysgeusia—Naltrexone—alcohol dependence	0.00253	0.00455	CcSEcCtD
Valsartan—Back pain—Naltrexone—alcohol dependence	0.0025	0.0045	CcSEcCtD
Valsartan—Angioedema—Acamprosate—alcohol dependence	0.0025	0.00449	CcSEcCtD
Valsartan—Muscle spasms—Naltrexone—alcohol dependence	0.00249	0.00447	CcSEcCtD
Valsartan—Orthostatic hypotension—Citalopram—alcohol dependence	0.00248	0.00447	CcSEcCtD
Valsartan—Abdominal pain upper—Citalopram—alcohol dependence	0.00248	0.00447	CcSEcCtD
Valsartan—Vertigo—Acamprosate—alcohol dependence	0.00246	0.00442	CcSEcCtD
Valsartan—Syncope—Acamprosate—alcohol dependence	0.00245	0.00441	CcSEcCtD
Valsartan—Cramp muscle—Citalopram—alcohol dependence	0.00245	0.00441	CcSEcCtD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.00245	0.0141	CbGpPWpGaD
Valsartan—Vision blurred—Naltrexone—alcohol dependence	0.00244	0.00438	CcSEcCtD
Valsartan—Palpitations—Acamprosate—alcohol dependence	0.00242	0.00434	CcSEcCtD
Valsartan—Loss of consciousness—Acamprosate—alcohol dependence	0.0024	0.00432	CcSEcCtD
Valsartan—Muscular weakness—Citalopram—alcohol dependence	0.0024	0.00432	CcSEcCtD
Valsartan—Cough—Acamprosate—alcohol dependence	0.00238	0.00429	CcSEcCtD
Valsartan—Angioedema—Naltrexone—alcohol dependence	0.00236	0.00425	CcSEcCtD
Valsartan—SLCO1B3—liver—alcohol dependence	0.00236	0.0638	CbGeAlD
Valsartan—Myalgia—Acamprosate—alcohol dependence	0.00233	0.00419	CcSEcCtD
Valsartan—Chest pain—Acamprosate—alcohol dependence	0.00233	0.00419	CcSEcCtD
Valsartan—Arthralgia—Acamprosate—alcohol dependence	0.00233	0.00419	CcSEcCtD
Valsartan—Syncope—Naltrexone—alcohol dependence	0.00232	0.00417	CcSEcCtD
Valsartan—Anxiety—Acamprosate—alcohol dependence	0.00232	0.00417	CcSEcCtD
Valsartan—AGTR1—cardiovascular system—alcohol dependence	0.00231	0.0626	CbGeAlD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00231	0.00416	CcSEcCtD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00231	0.0133	CbGpPWpGaD
Valsartan—Palpitations—Naltrexone—alcohol dependence	0.00229	0.00411	CcSEcCtD
Valsartan—Dry mouth—Acamprosate—alcohol dependence	0.00228	0.00409	CcSEcCtD
Valsartan—Loss of consciousness—Naltrexone—alcohol dependence	0.00227	0.00409	CcSEcCtD
Valsartan—Bronchitis—Citalopram—alcohol dependence	0.00226	0.00407	CcSEcCtD
Valsartan—Cough—Naltrexone—alcohol dependence	0.00226	0.00406	CcSEcCtD
Valsartan—Anaphylactic shock—Acamprosate—alcohol dependence	0.00223	0.00401	CcSEcCtD
Valsartan—Infection—Acamprosate—alcohol dependence	0.00222	0.00399	CcSEcCtD
Valsartan—Arthralgia—Naltrexone—alcohol dependence	0.0022	0.00396	CcSEcCtD
Valsartan—Chest pain—Naltrexone—alcohol dependence	0.0022	0.00396	CcSEcCtD
Valsartan—Myalgia—Naltrexone—alcohol dependence	0.0022	0.00396	CcSEcCtD
Valsartan—Shock—Acamprosate—alcohol dependence	0.00219	0.00395	CcSEcCtD
Valsartan—Anxiety—Naltrexone—alcohol dependence	0.00219	0.00395	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00219	0.00393	CcSEcCtD
Valsartan—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00219	0.00393	CcSEcCtD
Valsartan—Thrombocytopenia—Acamprosate—alcohol dependence	0.00218	0.00393	CcSEcCtD
Valsartan—Skin disorder—Acamprosate—alcohol dependence	0.00217	0.0039	CcSEcCtD
Valsartan—Erectile dysfunction—Citalopram—alcohol dependence	0.00217	0.0039	CcSEcCtD
Valsartan—Dry mouth—Naltrexone—alcohol dependence	0.00215	0.00387	CcSEcCtD
Valsartan—Photosensitivity reaction—Citalopram—alcohol dependence	0.00215	0.00386	CcSEcCtD
Valsartan—Anorexia—Acamprosate—alcohol dependence	0.00213	0.00382	CcSEcCtD
Valsartan—Oedema—Naltrexone—alcohol dependence	0.00211	0.0038	CcSEcCtD
Valsartan—Anaphylactic shock—Naltrexone—alcohol dependence	0.00211	0.0038	CcSEcCtD
Valsartan—AGTR1—Peptide ligand-binding receptors—OPRD1—alcohol dependence	0.0021	0.0121	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.0021	0.0121	CbGpPWpGaD
Valsartan—Infection—Naltrexone—alcohol dependence	0.0021	0.00377	CcSEcCtD
Valsartan—Infestation—Citalopram—alcohol dependence	0.0021	0.00377	CcSEcCtD
Valsartan—Infestation NOS—Citalopram—alcohol dependence	0.0021	0.00377	CcSEcCtD
Valsartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—alcohol dependence	0.00209	0.012	CbGpPWpGaD
Valsartan—Hypotension—Acamprosate—alcohol dependence	0.00208	0.00375	CcSEcCtD
Valsartan—Shock—Naltrexone—alcohol dependence	0.00208	0.00373	CcSEcCtD
Valsartan—Nervous system disorder—Naltrexone—alcohol dependence	0.00207	0.00372	CcSEcCtD
Valsartan—Skin disorder—Naltrexone—alcohol dependence	0.00205	0.00369	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00203	0.00366	CcSEcCtD
Valsartan—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.00203	0.0117	CbGpPWpGaD
Valsartan—Insomnia—Acamprosate—alcohol dependence	0.00202	0.00363	CcSEcCtD
Valsartan—AGTR1—Peptide ligand-binding receptors—PDYN—alcohol dependence	0.00202	0.0116	CbGpPWpGaD
Valsartan—Anorexia—Naltrexone—alcohol dependence	0.00201	0.00362	CcSEcCtD
Valsartan—Paraesthesia—Acamprosate—alcohol dependence	0.002	0.0036	CcSEcCtD
Valsartan—Dyspnoea—Acamprosate—alcohol dependence	0.00199	0.00358	CcSEcCtD
Valsartan—Somnolence—Acamprosate—alcohol dependence	0.00198	0.00357	CcSEcCtD
Valsartan—Epistaxis—Citalopram—alcohol dependence	0.00198	0.00356	CcSEcCtD
Valsartan—Sinusitis—Citalopram—alcohol dependence	0.00197	0.00354	CcSEcCtD
Valsartan—Dyspepsia—Acamprosate—alcohol dependence	0.00196	0.00353	CcSEcCtD
Valsartan—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00195	0.0112	CbGpPWpGaD
Valsartan—Decreased appetite—Acamprosate—alcohol dependence	0.00194	0.00349	CcSEcCtD
Valsartan—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00193	0.00346	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00192	0.00346	CcSEcCtD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00191	0.011	CbGpPWpGaD
Valsartan—Insomnia—Naltrexone—alcohol dependence	0.00191	0.00343	CcSEcCtD
Valsartan—Constipation—Acamprosate—alcohol dependence	0.00191	0.00343	CcSEcCtD
Valsartan—Paraesthesia—Naltrexone—alcohol dependence	0.00189	0.00341	CcSEcCtD
Valsartan—Haemoglobin—Citalopram—alcohol dependence	0.00189	0.0034	CcSEcCtD
Valsartan—Rhinitis—Citalopram—alcohol dependence	0.00189	0.00339	CcSEcCtD
Valsartan—Hepatitis—Citalopram—alcohol dependence	0.00188	0.00339	CcSEcCtD
Valsartan—Haemorrhage—Citalopram—alcohol dependence	0.00188	0.00339	CcSEcCtD
Valsartan—Dyspnoea—Naltrexone—alcohol dependence	0.00188	0.00338	CcSEcCtD
Valsartan—Somnolence—Naltrexone—alcohol dependence	0.00188	0.00337	CcSEcCtD
Valsartan—Pharyngitis—Citalopram—alcohol dependence	0.00187	0.00336	CcSEcCtD
Valsartan—Urinary tract disorder—Citalopram—alcohol dependence	0.00186	0.00334	CcSEcCtD
Valsartan—Connective tissue disorder—Citalopram—alcohol dependence	0.00185	0.00333	CcSEcCtD
Valsartan—Urethral disorder—Citalopram—alcohol dependence	0.00184	0.00332	CcSEcCtD
Valsartan—Decreased appetite—Naltrexone—alcohol dependence	0.00183	0.0033	CcSEcCtD
Valsartan—SLCO1B1—digestive system—alcohol dependence	0.00183	0.0496	CbGeAlD
Valsartan—AGTR1—blood—alcohol dependence	0.00183	0.0495	CbGeAlD
Valsartan—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00182	0.00328	CcSEcCtD
Valsartan—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00182	0.00328	CcSEcCtD
Valsartan—Fatigue—Naltrexone—alcohol dependence	0.00182	0.00327	CcSEcCtD
Valsartan—Constipation—Naltrexone—alcohol dependence	0.0018	0.00325	CcSEcCtD
Valsartan—Urticaria—Acamprosate—alcohol dependence	0.00177	0.00319	CcSEcCtD
Valsartan—Abdominal pain—Acamprosate—alcohol dependence	0.00176	0.00317	CcSEcCtD
Valsartan—Cardiac disorder—Citalopram—alcohol dependence	0.00175	0.00314	CcSEcCtD
Valsartan—SLCO1B1—blood—alcohol dependence	0.00174	0.0472	CbGeAlD
Valsartan—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00173	0.0031	CcSEcCtD
Valsartan—Angiopathy—Citalopram—alcohol dependence	0.00171	0.00307	CcSEcCtD
Valsartan—Immune system disorder—Citalopram—alcohol dependence	0.0017	0.00306	CcSEcCtD
Valsartan—Mediastinal disorder—Citalopram—alcohol dependence	0.0017	0.00305	CcSEcCtD
Valsartan—Urticaria—Naltrexone—alcohol dependence	0.00168	0.00302	CcSEcCtD
Valsartan—Abdominal pain—Naltrexone—alcohol dependence	0.00167	0.003	CcSEcCtD
Valsartan—Alopecia—Citalopram—alcohol dependence	0.00166	0.00299	CcSEcCtD
Valsartan—Mental disorder—Citalopram—alcohol dependence	0.00165	0.00297	CcSEcCtD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.00165	0.00947	CbGpPWpGaD
Valsartan—Hypersensitivity—Acamprosate—alcohol dependence	0.00164	0.00296	CcSEcCtD
Valsartan—Malnutrition—Citalopram—alcohol dependence	0.00164	0.00295	CcSEcCtD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00163	0.00935	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—OPRM1—alcohol dependence	0.00162	0.00931	CbGpPWpGaD
Valsartan—Flatulence—Citalopram—alcohol dependence	0.00161	0.0029	CcSEcCtD
Valsartan—Dysgeusia—Citalopram—alcohol dependence	0.0016	0.00289	CcSEcCtD
Valsartan—Asthenia—Acamprosate—alcohol dependence	0.0016	0.00288	CcSEcCtD
Valsartan—AGTR1—GPCR ligand binding—OPRK1—alcohol dependence	0.0016	0.00919	CbGpPWpGaD
Valsartan—AGTR1—endocrine gland—alcohol dependence	0.00159	0.043	CbGeAlD
Valsartan—Back pain—Citalopram—alcohol dependence	0.00158	0.00285	CcSEcCtD
Valsartan—Pruritus—Acamprosate—alcohol dependence	0.00158	0.00284	CcSEcCtD
Valsartan—Muscle spasms—Citalopram—alcohol dependence	0.00158	0.00283	CcSEcCtD
Valsartan—Hypersensitivity—Naltrexone—alcohol dependence	0.00155	0.0028	CcSEcCtD
Valsartan—Vision blurred—Citalopram—alcohol dependence	0.00154	0.00278	CcSEcCtD
Valsartan—Diarrhoea—Acamprosate—alcohol dependence	0.00153	0.00275	CcSEcCtD
Valsartan—Asthenia—Naltrexone—alcohol dependence	0.00151	0.00272	CcSEcCtD
Valsartan—AGTR1—testis—alcohol dependence	0.00151	0.041	CbGeAlD
Valsartan—SLCO1B1—endocrine gland—alcohol dependence	0.00151	0.041	CbGeAlD
Valsartan—Angioedema—Citalopram—alcohol dependence	0.0015	0.00269	CcSEcCtD
Valsartan—Pruritus—Naltrexone—alcohol dependence	0.00149	0.00269	CcSEcCtD
Valsartan—AGTR1—Peptide ligand-binding receptors—NPY—alcohol dependence	0.00149	0.00856	CbGpPWpGaD
Valsartan—AGTR1—nervous system—alcohol dependence	0.00148	0.0402	CbGeAlD
Valsartan—Dizziness—Acamprosate—alcohol dependence	0.00147	0.00265	CcSEcCtD
Valsartan—Vertigo—Citalopram—alcohol dependence	0.00147	0.00265	CcSEcCtD
Valsartan—ALB—Selenium Micronutrient Network—GGT2—alcohol dependence	0.00147	0.00846	CbGpPWpGaD
Valsartan—Syncope—Citalopram—alcohol dependence	0.00147	0.00264	CcSEcCtD
Valsartan—Palpitations—Citalopram—alcohol dependence	0.00145	0.0026	CcSEcCtD
Valsartan—Diarrhoea—Naltrexone—alcohol dependence	0.00144	0.0026	CcSEcCtD
Valsartan—Loss of consciousness—Citalopram—alcohol dependence	0.00144	0.00259	CcSEcCtD
Valsartan—AGTR1—liver—alcohol dependence	0.00143	0.0387	CbGeAlD
Valsartan—Cough—Citalopram—alcohol dependence	0.00143	0.00257	CcSEcCtD
Valsartan—AGTR1—central nervous system—alcohol dependence	0.00143	0.0387	CbGeAlD
Valsartan—Vomiting—Acamprosate—alcohol dependence	0.00142	0.00255	CcSEcCtD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00141	0.00811	CbGpPWpGaD
Valsartan—Rash—Acamprosate—alcohol dependence	0.00141	0.00253	CcSEcCtD
Valsartan—Dermatitis—Acamprosate—alcohol dependence	0.00141	0.00253	CcSEcCtD
Valsartan—Headache—Acamprosate—alcohol dependence	0.0014	0.00251	CcSEcCtD
Valsartan—Dizziness—Naltrexone—alcohol dependence	0.0014	0.00251	CcSEcCtD
Valsartan—Arthralgia—Citalopram—alcohol dependence	0.00139	0.00251	CcSEcCtD
Valsartan—Myalgia—Citalopram—alcohol dependence	0.00139	0.00251	CcSEcCtD
Valsartan—Chest pain—Citalopram—alcohol dependence	0.00139	0.00251	CcSEcCtD
Valsartan—Anxiety—Citalopram—alcohol dependence	0.00139	0.0025	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00139	0.00249	CcSEcCtD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00138	0.00795	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.00138	0.00794	CbGpPWpGaD
Valsartan—Dry mouth—Citalopram—alcohol dependence	0.00136	0.00245	CcSEcCtD
Valsartan—SLCO1B1—liver—alcohol dependence	0.00136	0.0369	CbGeAlD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.00135	0.00778	CbGpPWpGaD
Valsartan—Vomiting—Naltrexone—alcohol dependence	0.00134	0.00241	CcSEcCtD
Valsartan—Anaphylactic shock—Citalopram—alcohol dependence	0.00134	0.00241	CcSEcCtD
Valsartan—Oedema—Citalopram—alcohol dependence	0.00134	0.00241	CcSEcCtD
Valsartan—Rash—Naltrexone—alcohol dependence	0.00133	0.00239	CcSEcCtD
Valsartan—Dermatitis—Naltrexone—alcohol dependence	0.00133	0.00239	CcSEcCtD
Valsartan—Infection—Citalopram—alcohol dependence	0.00133	0.00239	CcSEcCtD
Valsartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00133	0.00763	CbGpPWpGaD
Valsartan—Nausea—Acamprosate—alcohol dependence	0.00132	0.00238	CcSEcCtD
Valsartan—Headache—Naltrexone—alcohol dependence	0.00132	0.00238	CcSEcCtD
Valsartan—Shock—Citalopram—alcohol dependence	0.00132	0.00237	CcSEcCtD
Valsartan—Nervous system disorder—Citalopram—alcohol dependence	0.00131	0.00236	CcSEcCtD
Valsartan—Thrombocytopenia—Citalopram—alcohol dependence	0.00131	0.00235	CcSEcCtD
Valsartan—Skin disorder—Citalopram—alcohol dependence	0.0013	0.00234	CcSEcCtD
Valsartan—Anorexia—Citalopram—alcohol dependence	0.00127	0.00229	CcSEcCtD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.00127	0.00729	CbGpPWpGaD
Valsartan—Nausea—Naltrexone—alcohol dependence	0.00125	0.00225	CcSEcCtD
Valsartan—Hypotension—Citalopram—alcohol dependence	0.00125	0.00225	CcSEcCtD
Valsartan—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.00123	0.00705	CbGpPWpGaD
Valsartan—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00122	0.00219	CcSEcCtD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00121	0.00697	CbGpPWpGaD
Valsartan—Insomnia—Citalopram—alcohol dependence	0.00121	0.00218	CcSEcCtD
Valsartan—Paraesthesia—Citalopram—alcohol dependence	0.0012	0.00216	CcSEcCtD
Valsartan—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—alcohol dependence	0.0012	0.00687	CbGpPWpGaD
Valsartan—Dyspnoea—Citalopram—alcohol dependence	0.00119	0.00214	CcSEcCtD
Valsartan—Somnolence—Citalopram—alcohol dependence	0.00119	0.00214	CcSEcCtD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.00118	0.0068	CbGpPWpGaD
Valsartan—Dyspepsia—Citalopram—alcohol dependence	0.00118	0.00212	CcSEcCtD
Valsartan—ALB—testis—alcohol dependence	0.00117	0.0316	CbGeAlD
Valsartan—Decreased appetite—Citalopram—alcohol dependence	0.00116	0.00209	CcSEcCtD
Valsartan—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00115	0.00208	CcSEcCtD
Valsartan—Fatigue—Citalopram—alcohol dependence	0.00115	0.00207	CcSEcCtD
Valsartan—Constipation—Citalopram—alcohol dependence	0.00114	0.00206	CcSEcCtD
Valsartan—AGTR1—brain—alcohol dependence	0.00113	0.0307	CbGeAlD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.00112	0.00647	CbGpPWpGaD
Valsartan—CYP2C9—cardiovascular system—alcohol dependence	0.00111	0.0302	CbGeAlD
Valsartan—ALB—liver—alcohol dependence	0.0011	0.0299	CbGeAlD
Valsartan—Gastrointestinal pain—Citalopram—alcohol dependence	0.00109	0.00197	CcSEcCtD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.00109	0.00624	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—OPRD1—alcohol dependence	0.00107	0.00618	CbGpPWpGaD
Valsartan—Urticaria—Citalopram—alcohol dependence	0.00106	0.00191	CcSEcCtD
Valsartan—Abdominal pain—Citalopram—alcohol dependence	0.00106	0.0019	CcSEcCtD
Valsartan—AGTR1—GPCR ligand binding—PDYN—alcohol dependence	0.00103	0.00592	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.00102	0.00584	CbGpPWpGaD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.001	0.00578	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000999	0.00574	CbGpPWpGaD
Valsartan—AGTR1—G alpha (q) signalling events—AVP—alcohol dependence	0.000997	0.00574	CbGpPWpGaD
Valsartan—Hypersensitivity—Citalopram—alcohol dependence	0.000985	0.00177	CcSEcCtD
Valsartan—AGTR1—Peptide ligand-binding receptors—AVP—alcohol dependence	0.000985	0.00566	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.000983	0.00565	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.000964	0.00554	CbGpPWpGaD
Valsartan—Asthenia—Citalopram—alcohol dependence	0.000959	0.00173	CcSEcCtD
Valsartan—AGTR1—GPCR ligand binding—CRHR1—alcohol dependence	0.000957	0.00551	CbGpPWpGaD
Valsartan—Pruritus—Citalopram—alcohol dependence	0.000946	0.0017	CcSEcCtD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000939	0.0054	CbGpPWpGaD
Valsartan—CYP2C9—digestive system—alcohol dependence	0.000924	0.025	CbGeAlD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.000916	0.00527	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.000916	0.00527	CbGpPWpGaD
Valsartan—Diarrhoea—Citalopram—alcohol dependence	0.000915	0.00165	CcSEcCtD
Valsartan—AGTR1—GPCR downstream signaling—OPRK1—alcohol dependence	0.000903	0.00519	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CHRM2—alcohol dependence	0.0009	0.00518	CbGpPWpGaD
Valsartan—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000895	0.00515	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000892	0.00513	CbGpPWpGaD
Valsartan—Dizziness—Citalopram—alcohol dependence	0.000884	0.00159	CcSEcCtD
Valsartan—CYP2C9—blood—alcohol dependence	0.00088	0.0239	CbGeAlD
Valsartan—ALB—brain—alcohol dependence	0.000875	0.0237	CbGeAlD
Valsartan—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000864	0.00497	CbGpPWpGaD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000854	0.00491	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000853	0.00491	CbGpPWpGaD
Valsartan—Vomiting—Citalopram—alcohol dependence	0.00085	0.00153	CcSEcCtD
Valsartan—Rash—Citalopram—alcohol dependence	0.000843	0.00152	CcSEcCtD
Valsartan—Dermatitis—Citalopram—alcohol dependence	0.000842	0.00152	CcSEcCtD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000842	0.00484	CbGpPWpGaD
Valsartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000842	0.00484	CbGpPWpGaD
Valsartan—Headache—Citalopram—alcohol dependence	0.000838	0.00151	CcSEcCtD
Valsartan—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000831	0.00478	CbGpPWpGaD
Valsartan—AGTR1—G alpha (q) signalling events—HTR2A—alcohol dependence	0.00083	0.00477	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—OPRM1—alcohol dependence	0.000826	0.00475	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—OPRK1—alcohol dependence	0.00082	0.00472	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000808	0.00465	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000804	0.00463	CbGpPWpGaD
Valsartan—Nausea—Citalopram—alcohol dependence	0.000794	0.00143	CcSEcCtD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000785	0.00451	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000785	0.00451	CbGpPWpGaD
Valsartan—CYP2C9—endocrine gland—alcohol dependence	0.000764	0.0207	CbGeAlD
Valsartan—AGTR1—GPCR ligand binding—NPY—alcohol dependence	0.000761	0.00437	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.000742	0.00427	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000734	0.00422	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CRH—alcohol dependence	0.000734	0.00422	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—HTR1B—alcohol dependence	0.000734	0.00422	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000725	0.00417	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000704	0.00405	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000695	0.004	CbGpPWpGaD
Valsartan—CYP2C9—liver—alcohol dependence	0.000689	0.0187	CbGeAlD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000683	0.00393	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000668	0.00384	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ADH6—alcohol dependence	0.000667	0.00384	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.00066	0.0038	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—POMC—alcohol dependence	0.000654	0.00376	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000644	0.0037	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000641	0.00369	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—DRD4—alcohol dependence	0.000641	0.00369	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CNR1—alcohol dependence	0.000612	0.00352	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—OPRD1—alcohol dependence	0.000607	0.00349	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—HTR7—alcohol dependence	0.000597	0.00344	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—DRD2—alcohol dependence	0.000597	0.00344	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—PDYN—alcohol dependence	0.000582	0.00335	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000573	0.0033	CbGpPWpGaD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000562	0.00323	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ADH1A—alcohol dependence	0.000553	0.00318	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—OPRD1—alcohol dependence	0.000551	0.00317	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.00055	0.00316	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000543	0.00312	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CRHR1—alcohol dependence	0.000541	0.00311	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000533	0.00307	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—PDYN—alcohol dependence	0.000528	0.00304	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CHRM2—alcohol dependence	0.000509	0.00293	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—AVP—alcohol dependence	0.000503	0.00289	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CRHR1—alcohol dependence	0.000491	0.00283	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000487	0.0028	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—OPRK1—alcohol dependence	0.000484	0.00279	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ADH4—alcohol dependence	0.00047	0.0027	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—OPRM1—alcohol dependence	0.000467	0.00269	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CHRM2—alcohol dependence	0.000462	0.00266	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000454	0.00261	CbGpPWpGaD
Valsartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000451	0.00259	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000449	0.00258	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ADH6—alcohol dependence	0.000448	0.00258	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000439	0.00252	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—NPY—alcohol dependence	0.00043	0.00247	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—OPRM1—alcohol dependence	0.000424	0.00244	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—HTR2A—alcohol dependence	0.000418	0.00241	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CRH—alcohol dependence	0.000415	0.00239	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR1B—alcohol dependence	0.000415	0.00239	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000411	0.00236	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000407	0.00234	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ADH7—alcohol dependence	0.0004	0.0023	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—NPY—alcohol dependence	0.00039	0.00225	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GGT2—alcohol dependence	0.000383	0.0022	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CRH—alcohol dependence	0.000377	0.00217	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR1B—alcohol dependence	0.000377	0.00217	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ADH1A—alcohol dependence	0.000371	0.00214	CbGpPWpGaD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000366	0.0021	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000363	0.00209	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—DRD4—alcohol dependence	0.000362	0.00208	CbGpPWpGaD
Valsartan—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000358	0.00206	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ADH1B—alcohol dependence	0.00035	0.00202	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CNR1—alcohol dependence	0.000346	0.00199	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—AVP—alcohol dependence	0.00034	0.00195	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—DRD2—alcohol dependence	0.000338	0.00194	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR7—alcohol dependence	0.000338	0.00194	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—POMC—alcohol dependence	0.000334	0.00192	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000333	0.00192	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—DRD4—alcohol dependence	0.000329	0.00189	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000328	0.00188	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—OPRD1—alcohol dependence	0.000326	0.00187	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ADH4—alcohol dependence	0.000316	0.00182	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CNR1—alcohol dependence	0.000314	0.00181	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PDYN—alcohol dependence	0.000312	0.0018	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.00031	0.00178	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—DRD2—alcohol dependence	0.000307	0.00176	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR7—alcohol dependence	0.000307	0.00176	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000298	0.00172	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MAOB—alcohol dependence	0.00029	0.00167	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—WASF2—alcohol dependence	0.00029	0.00167	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CRHR1—alcohol dependence	0.00029	0.00167	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—AVP—alcohol dependence	0.000284	0.00163	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000278	0.0016	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—WASF1—alcohol dependence	0.000278	0.0016	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000276	0.00159	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000273	0.00157	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CHRM2—alcohol dependence	0.000273	0.00157	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ADH7—alcohol dependence	0.000268	0.00154	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—AVP—alcohol dependence	0.000258	0.00148	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GGT2—alcohol dependence	0.000257	0.00148	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000257	0.00148	CbGpPWpGaD
Valsartan—ALB—Metabolism—ADH6—alcohol dependence	0.000256	0.00147	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—OPRM1—alcohol dependence	0.000251	0.00144	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ALDH2—alcohol dependence	0.000247	0.00142	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000237	0.00137	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR2A—alcohol dependence	0.000236	0.00136	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ADH1B—alcohol dependence	0.000235	0.00135	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NPY—alcohol dependence	0.000231	0.00133	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000228	0.00131	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR1B—alcohol dependence	0.000222	0.00128	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CRH—alcohol dependence	0.000222	0.00128	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR2A—alcohol dependence	0.000215	0.00124	CbGpPWpGaD
Valsartan—ALB—Metabolism—ADH1A—alcohol dependence	0.000212	0.00122	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GOT2—alcohol dependence	0.00021	0.00121	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ADH6—alcohol dependence	0.00021	0.00121	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CYP2E1—alcohol dependence	0.000197	0.00114	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MAOB—alcohol dependence	0.000195	0.00112	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DRD4—alcohol dependence	0.000194	0.00112	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—POMC—alcohol dependence	0.000194	0.00112	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—POMC—alcohol dependence	0.000189	0.00109	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CNR1—alcohol dependence	0.000186	0.00107	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GGT1—alcohol dependence	0.000181	0.00104	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GOT1—alcohol dependence	0.000181	0.00104	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DRD2—alcohol dependence	0.000181	0.00104	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR7—alcohol dependence	0.000181	0.00104	CbGpPWpGaD
Valsartan—ALB—Metabolism—ADH4—alcohol dependence	0.00018	0.00104	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ADH1A—alcohol dependence	0.000174	0.000999	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—POMC—alcohol dependence	0.000172	0.000987	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALDH2—alcohol dependence	0.000166	0.000954	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MAOA—alcohol dependence	0.000162	0.000934	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000159	0.000917	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000158	0.000907	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000157	0.000906	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000156	0.000898	CbGpPWpGaD
Valsartan—ALB—Metabolism—ADH7—alcohol dependence	0.000153	0.000882	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—AVP—alcohol dependence	0.000152	0.000877	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ADH4—alcohol dependence	0.000148	0.000849	CbGpPWpGaD
Valsartan—ALB—Metabolism—GGT2—alcohol dependence	0.000147	0.000846	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GOT2—alcohol dependence	0.000141	0.000811	CbGpPWpGaD
Valsartan—ALB—Metabolism—ADH1B—alcohol dependence	0.000135	0.000774	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP2E1—alcohol dependence	0.000133	0.000763	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—AVP—alcohol dependence	0.00013	0.00075	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000128	0.000735	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR2A—alcohol dependence	0.000127	0.00073	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ADH7—alcohol dependence	0.000126	0.000722	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GGT1—alcohol dependence	0.000122	0.0007	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GOT1—alcohol dependence	0.000122	0.0007	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GGT2—alcohol dependence	0.00012	0.000692	CbGpPWpGaD
Valsartan—ALB—Metabolism—MAOB—alcohol dependence	0.000111	0.000641	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ADH1B—alcohol dependence	0.00011	0.000633	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MAOA—alcohol dependence	0.000109	0.000628	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000106	0.000609	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—POMC—alcohol dependence	0.000106	0.000608	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—POMC—alcohol dependence	0.000101	0.000583	CbGpPWpGaD
Valsartan—ALB—Metabolism—ALDH2—alcohol dependence	9.48e-05	0.000545	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MAOB—alcohol dependence	9.12e-05	0.000525	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	9.11e-05	0.000524	CbGpPWpGaD
Valsartan—ALB—Metabolism—GOT2—alcohol dependence	8.06e-05	0.000464	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALDH2—alcohol dependence	7.76e-05	0.000446	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP2E1—alcohol dependence	7.58e-05	0.000436	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	7.46e-05	0.000429	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—POMC—alcohol dependence	7.1e-05	0.000409	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—EP300—alcohol dependence	7.01e-05	0.000403	CbGpPWpGaD
Valsartan—ALB—Metabolism—GGT1—alcohol dependence	6.96e-05	0.0004	CbGpPWpGaD
Valsartan—ALB—Metabolism—GOT1—alcohol dependence	6.96e-05	0.0004	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EP300—alcohol dependence	6.72e-05	0.000387	CbGpPWpGaD
Valsartan—ALB—Hemostasis—EP300—alcohol dependence	6.64e-05	0.000382	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GOT2—alcohol dependence	6.6e-05	0.000379	CbGpPWpGaD
Valsartan—ALB—Metabolism—MAOA—alcohol dependence	6.23e-05	0.000359	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP2E1—alcohol dependence	6.2e-05	0.000357	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	6.05e-05	0.000348	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GOT1—alcohol dependence	5.69e-05	0.000328	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GGT1—alcohol dependence	5.69e-05	0.000328	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MAOA—alcohol dependence	5.1e-05	0.000294	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	4.95e-05	0.000285	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—EP300—alcohol dependence	4.71e-05	0.000271	CbGpPWpGaD
Valsartan—ALB—Metabolism—POMC—alcohol dependence	4.06e-05	0.000233	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—POMC—alcohol dependence	3.32e-05	0.000191	CbGpPWpGaD
Valsartan—ALB—Metabolism—EP300—alcohol dependence	2.69e-05	0.000155	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—EP300—alcohol dependence	2.2e-05	0.000127	CbGpPWpGaD
